Prognostic value of cartilage intermediate layer protein 1 in chronic heart failure

Aims Emerging evidence suggests that cartilage intermediate layer protein 1 (CILP‐1) is associated with myocardial remodelling. However, the prognostic value of circulating CILP‐1 in patients with heart failure (HF) remains to be elucidated. This study aimed to investigate whether circulating CILP‐1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ESC Heart Failure 2022-02, Vol.9 (1), p.345-352
Hauptverfasser:	Wang, Can, Jian, Wen, Luo, Qiuhu, Cui, Jiasheng, Qing, Yali, Qin, Chunyu, Li, Gaoye, Chen, Wuxian
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarker Biomarkers Blood pressure Body mass index Cartilage Chronic obstructive pulmonary disease CILP‐1 Creatinine Diabetes Ejection fraction Enzymes Fibroblasts Heart Failure Heart rate Hemoglobin Hospitals Humans Hypertension Mortality Natriuretic Peptide, Brain Original Peptides Prognosis Prospective Studies Proteins Standard deviation Stroke Volume Survival analysis Uric acid Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims Emerging evidence suggests that cartilage intermediate layer protein 1 (CILP‐1) is associated with myocardial remodelling. However, the prognostic value of circulating CILP‐1 in patients with heart failure (HF) remains to be elucidated. This study aimed to investigate whether circulating CILP‐1 can independently predict the outcome of chronic HF. Methods and results This prospective cohort study included 210 patients with chronic HF and left ventricular ejection fraction
ISSN:	2055-5822 2055-5822
DOI:	10.1002/ehf2.13746